Dit is een extensieve samenvatting voor FABA304 - Oncologie, waarop de focus gelegd is op het boek Molecular Biology of Cancer van Lauren Pecorino. Ik heb echt alle details van dit boek eruit gehaald - precies de dingen waar je overheen leest, omdat je denkt dat het niet belangrijk is voor het tent...
Hoofdstuk 3 (wc 1)................................................................................................................. 5
§3.1 transcription factors and transcriptional regulation.....................................................5
§3.2 chromatin structure.....................................................................................................6
§3.3 epigenetic regulation of transcription..........................................................................7
Histone modification..................................................................................................... 7
DNA Methylation.......................................................................................................... 8
§3.4 evidence of a role for epigenetics in carcinogenesis..................................................8
Histone modication and cancer.................................................................................... 8
Methylation and cancer................................................................................................ 8
§3.5 long non-coding RNAs............................................................................................... 8
§3.6 microRNAs and regulation of mRNA expression....................................................... 9
§3.7 telomeren en telomerase............................................................................................9
§3.8 epigenomic and histonomic drugs............................................................................10
DNA methylation inhibitors......................................................................................... 10
Inhibitors of histone deacetylases.............................................................................. 10
§3.9 Non-coding RNAs for diagnosis............................................................................... 10
§3.10 telomerase inhibitors.............................................................................................. 10
Hoofdstuk 4 (owg 1)............................................................................................................. 10
§4.1 epidermal growth factor signaling: an important paradigm.......................................11
1. Growth factor binding..............................................................................................11
2. Dimerization............................................................................................................11
3. Autophosphorylation............................................................................................... 11
4. Translocatie van specifieke eiwitten naar het membraan.......................................12
5. RAS activation........................................................................................................ 12
6. Raf activation..........................................................................................................12
7. The MAPK kinase cascade.................................................................................... 12
8. Regulation of transcription factors..........................................................................13
The effect of cell signaling on cell behavior................................................................13
§4.2 oncogenes................................................................................................................14
Studies of retroviruses................................................................................................14
Growth factors............................................................................................................ 14
Growth factor receptors.............................................................................................. 14
Intracellular signal transducers...................................................................................15
Transcription factors................................................................................................... 15
Mechanisms of oncogenic mutations......................................................................... 15
§4.3 kinases as drug targets............................................................................................ 16
Anti-EGFR drugs........................................................................................................ 16
Strategies against Ras and Raf..................................................................................16
MEK inhibitors............................................................................................................ 16
Hoofdstuk 6 (owg 1)............................................................................................................. 17
§6.1 definitions of tumor supressor genes....................................................................... 17
§6.2 the retinoblastoma gene...........................................................................................17
§6.3 mutations in the RB pathway and cancer.................................................................17
, §6.4 the p53 pathway....................................................................................................... 18
Stucture of p53 protein............................................................................................... 18
Regulation of p53 protein by MDM2...........................................................................18
Upstream: molecular pathways van p53 activation.................................................... 19
Downstream: molecular mechanisms of p53 cellular effects......................................19
Inhibitie van de celcyclus......................................................................................19
Apoptosis..............................................................................................................20
DNA repair and angiogenesis and other emerging roles......................................21
Factors that decide downstream outcome: cell cycle arrest or apoptosis.................. 21
§6.5 mutations in the p53 pathway and cancer................................................................21
More complex than knudson’s two-hit hypothesis...................................................... 21
§6.6 interaction of DNA viral protein products with RB and p53...................................... 22
HPV causes cervical cancer.......................................................................................22
§6.7 targeting of the p53 pathway.................................................................................... 22
Strategies that aim to correct a p53 mutation.............................................................22
Hoofdstuk 2 (owg 2)............................................................................................................. 22
§2.1 gene structure.......................................................................................................... 22
§2.2 mutations..................................................................................................................23
§2.3 carcinogenic agents................................................................................................. 24
Radiation as a carcinogen..........................................................................................24
Ionizing radiation.................................................................................................. 24
Ultraviolet radiation...............................................................................................25
Chemical carcinogens.......................................................................................... 27
Infectious pathogens as carcinogens......................................................................... 28
Endogenous carcinogenic reactions.......................................................................... 28
§2.4 DNA repair and predispositions to cancer................................................................28
§2.5 conventional therapies: chemotherapy and radiation therapy..................................30
Chemotherapy............................................................................................................ 30
Alkylating agents and platinum-based drugs........................................................30
Antimetabolieten...................................................................................................31
Organische middelen............................................................................................31
Radiation therapy....................................................................................................... 31
Heterogeneous cell sensitivity and drug resistance................................................... 32
§2.6 strategies that target DNA repair pathways..............................................................32
Synthetic lethal strategies.......................................................................................... 32
Hoofdstuk 12 (owg 3)........................................................................................................... 33
§12.1 lymphocytes: B cells and T cells............................................................................ 33
§12.2 tumor suppresive roles of the immune system.......................................................34
The cancer immunity cycle......................................................................................... 34
§12.3 immune checkpoints...............................................................................................34
§12.4 cancer immunoediting and tumor promotion.......................................................... 35
§12.5 mechanisms of avoiding immune destruction........................................................ 35
§12.6 therapeutic antibodies............................................................................................ 36
§12.7 cancer vaccines......................................................................................................36
, Therapeutic vaccins................................................................................................... 36
Whole-cell vaccines..............................................................................................37
Peptide-based vaccines....................................................................................... 37
Dendritic cell vaccines.......................................................................................... 37
Vaccines for cancer prevention.................................................................................. 37
Hurdles to jump.......................................................................................................... 37
§12.8 immune checkpoint blockades............................................................................... 37
§12.9 adoptive T-cell transfer, modified T-cel receptors and chimeric antigen receptors.38
§12.10 oncolytic viruses and virotherapy......................................................................... 38
Hoofdstuk 5 (owg 4)............................................................................................................. 39
§5.1 cyclins and cyclin-dependent kinases (cdks)........................................................... 39
§5.2 mechanisms of cdk regulation..................................................................................40
§5.3 progression through the G1 checkpoint................................................................... 40
Structure of the RB protein......................................................................................... 40
Molecular mechanisms of the effects of RB............................................................... 41
§5.4 the G2 checkpoint.................................................................................................... 41
§5.5 the mitotic checkpoint...............................................................................................42
Aurora kinases........................................................................................................... 42
§5.6 the cell cycle and cancer.......................................................................................... 43
§5.7 cyclin-dependent kinase inhibitors........................................................................... 43
§5.8 other cell cycle kinase targets.................................................................................. 43
§5.9 inhibitors of the mitotic spindle................................................................................. 43
Hoofdstuk 7 (owg 4)............................................................................................................. 44
§7.1 molecular mechanisms of apoptosis........................................................................ 44
The extrinsic pathway: mediated by membrane death receptors...............................44
The intrinsic pathway: mediated by the mitochondria................................................ 45
Cross-talk between extrinsic and intrinsic pathways.................................................. 46
P53 and apoptosis......................................................................................................46
§7.2 apoptosis and cancer............................................................................................... 46
TRAIL receptors......................................................................................................... 47
Mutations that affect the extrinsic pathway.................................................................47
Mutations that affect regulators of the intrinsic pathway.............................................47
Alternative death pathways........................................................................................ 47
§7.3 Apoptosis and chemotherapy...................................................................................47
§7.4 apoptotic drugs.........................................................................................................48
Targeting TRAIL and its receptor................................................................................48
Regulation of the Bcl-2 family of proteins...................................................................48
Direct and indirect activation of caspases.................................................................. 48
Hoofdstuk 9 (hoorcollege)...................................................................................................48
9.1 How do tumors spread?............................................................................................. 49
9.2 The process of metastasis......................................................................................... 49
9.3 Invasion and epithelial-mesecnhymal transition.........................................................49
Induction of EMT........................................................................................................ 49
Tools of invasion......................................................................................................... 50
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper instaglam. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €5,99. Je zit daarna nergens aan vast.
